Foreword
Next-Generation Therapeutics Meet - Next-Generation Technologies
As we move into 2026, scientific breakthroughs, digital innovation, and shifting global dynamics are redefining how researchers...
Strategy
Energetic Chemistry in Pharma
Opportunity and Risk
Pharmaceutical innovation uses energetic chemistries: transformations that enable access to new molecular scaffolds...
Digital Quality Management Systems as Strategic Enablers of Patient-Centric Manufacturing Excellence
In the life sciences industry, quality is foundational. It underpins patient trust, ensures a reliable supply of medicines...
Navigating the U.S. CDMO Industry
Emerging Realities and Strategic Considerations
The post-pandemic belief that CDMOs would retain lasting pricing power has faded. The discussion at a major healthcare...
Research & Development
Antibody + Drug + Third Party, Antibody + siRNA/ASO + Third Party?
Re-imagining the Future of Therapeutics
Drug development continues to advance at a remarkable speed, yet the underlying paradox of the field remains unchanged...
GLP 1 at Scale
Why 2026 Will Reward Orchestrators, Not Capacity Builders
The GLP 1 boom has pushed the U.S. pharmaceutical industry into unfamiliar territory. Demand has outgrown not only...
Manufacturing
Redefining RNA Manufacturing Through Innovation in Biocatalysis
The global market for RNA therapeutics is projected to reach $25 billion by the early 2030s, a clear signal of the modality’s move...
Information Technology
AI in Pharmaceutical Manufacturing Operations
The pharmaceutical manufacturing landscape is undergoing a profound transformation driven by Artificial Intelligence...
Rise of AI/ML-Powered Accelerators in Pharma Secure Supply Chain
The pharmaceutical industry faces a defining moment. For over a decade, companies have invested billions in securing drugs...
Expert Talk
Strategic Visibility
How Media Partnerships Are Redefining B2B Pharma Events
Pharma events have transitioned from being standalone networking opportunities to becoming strategic industry platforms...
Microbiome and Microbial Omics Data in Clinical Stages
Exploring the Facts, Fictions, and Bottlenecks
Specifically in microbiome testing, there is so much to gain from a fast go-to-market strategy: that is the moment you start capturing...
Oligonucleotide CMC & Manufacturing
With the rapid expansion of oligonucleotide therapeutics into formats such as AOCs, novel conjugates, pegRNAs and multivalent...
Fundamentals and Design of Drug Delivery Systems
A Textbook with Lab Activities
Most engineering students lack foundational pharmacology knowledge, yet advanced drug delivery system design must be...
Single Use Technologies (SUT) in Pharmaceutical Manufacturing
SUT has shifted manufacturing toward speed, flexibility, and modular capacity. By replacing fixed stainless steel...
Advertorials
A New Chapter in PROCOS’ Growth Journey
PROCOS Advances Its Expansion Strategy With a New Production Building and Continues Its Sustainability Commitment
PROCOS S.p.A. stands as one of the historical players in the pharmaceutical industry, known for its excellence in the development...
The Evolution of Bioprocessing
Bridging Global Expertise with Local Innovation
In the rapidly advancing landscape of biopharmaceuticals, the demand for high-quality recombinant proteins and antibodies...
BioPharma
Navigating the Future
Regulatory Pathways for Advanced Therapies
Advanced therapies, like gene editing, personalised cell therapies, CAR T treatments, and tissue-engineered products...
